Guided Therapeutics (GTHP) Change in Receivables (2011 - 2025)
Guided Therapeutics (GTHP) posted Change in Receivables of $8000.0 for Q2 2025, up 900.0% sequentially from -$1000.0 in Q1 2025, and up 366.67% YoY from $1714.3 in Q2 2024.
Guided Therapeutics (GTHP) Change in Receivables (2011 - 2025) Analysis & Trends
Guided Therapeutics has reported Change in Receivables for 15 years, with the latest figure at $8000.0 in Q2 2025.
- Quarterly Change in Receivables rose 366.67% year-over-year to $8000.0 in Q2 2025, while the trailing twelve-month figure through Dec 2025 was $7000.0 (up 216.67% YoY) and the FY2025 annual result came in at $7000.0, up 216.67% from the prior year.
- Change in Receivables grew to $8000.0 in Q2 2025 per GTHP's latest filing, from -$1000.0 in the prior quarter.
- Over five years, Change in Receivables peaked at $22000.0 in Q4 2021 and troughed at -$32000.0 in Q3 2022.
- A 5-year average of $769.23 and a median of -$1000.0 in 2023 frame the typical range for Change in Receivables.
- The widest YoY moves for Change in Receivables: up 600.0% in 2022, down 1700.0% in 2022.
- Over 5 years, Change in Receivables stood at $22000.0 in 2021, then plunged by 245.45% to -$32000.0 in 2022, then soared by 112.5% to $4000.0 in 2023, then slumped by 150.0% to -$2000.0 in 2024, then soared by 500.0% to $8000.0 in 2025.
- According to Business Quant data, Change in Receivables over the past three periods registered $8000.0, -$1000.0, and -$2000.0 for Q2 2025, Q1 2025, and Q4 2024 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.72 Bn | 197.12 Bn | 7.27 Bn | 386.00 Mn |
| 2 | Stryker | 126.42 Bn | 122.94 Bn | 4.50 Bn | 177.00 Mn |
| 3 | Medtronic | 119.75 Bn | 110.53 Bn | 6.41 Bn | 287.00 Mn |
| 4 | Boston Scientific | 74.13 Bn | 73.60 Bn | 3.85 Bn | 46.00 Mn |
| 5 | Edwards Lifesciences | 51.78 Bn | 47.53 Bn | 1.35 Bn | 10.20 Mn |
| 6 | Dexcom | 35.29 Bn | 33.34 Bn | 830.00 Mn | 172.10 Mn |
| 7 | GE HealthCare Technologies | 33.95 Bn | 31.85 Bn | 2.18 Bn | 79.00 Mn |
| 8 | Koninklijke Philips | 26.22 Bn | 22.90 Bn | 4.55 Bn | - |
| 9 | Steris | 23.21 Bn | 22.73 Bn | 684.20 Mn | -90.00 Mn |
| 10 | Guided Therapeutics | 21.24 Mn | 21.23 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | 8,000.00 |
| Jun 30, 2025 | 8,000.00 |
| Mar 31, 2025 | -1,000.00 |
| Mar 31, 2025 | -1,000.00 |
| Dec 31, 2024 | -2,000.00 |
| Dec 31, 2024 | -2,000.00 |
| Jun 30, 2024 | -3,000.00 |
| Jun 30, 2024 | -3,000.00 |
| Mar 31, 2024 | -1,000.00 |
| Mar 31, 2024 | -1,000.00 |
| Jun 30, 2023 | 4,000.00 |
| Jun 30, 2023 | 4,000.00 |
| Mar 31, 2023 | -1,000.00 |
| Mar 31, 2023 | -1,000.00 |
| Sep 30, 2022 | -32,000.00 |
| Sep 30, 2022 | -32,000.00 |
| Jun 30, 2022 | 10,000.00 |
| Jun 30, 2022 | 10,000.00 |
| Mar 31, 2022 | 6,000.00 |
| Mar 31, 2022 | 6,000.00 |